The Motor Neurone Disease Behaviour Scale (MiND-B) is a valid, sensitive and short instrument that detects and quantifies behavioural changes in Amyotrophic Lateral Sclerosis (ALS). It measures three behavioural domains: apathy, disinhibition and stereotypical behaviour. The questionnaire contains 9 questions with a total score of 36, which higher scores denoting absence or very mild behavioural symptoms. The MiND-B can be completed by a caregiver/family member or clinician.
The MiND instrument and scoring guide can be downloaded below:
Wear, H.J., et al., The Cambridge Behavioural Inventory revised. Dementia & Neuropsychologia, 2008. 2(2): p. 102-107.
Neumann, M., et al., Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 2006. 314(5796): p. 130-3.
Lillo, P., et al., Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum. Amyotrophic Lateral Sclerosis, 2012. 13(1): p. 102-9.
Lillo, P., et al., Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS ONE, 2012. 7(8): p. e43993.
Stewart, H., et al., Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p. Acta Neuropathologica, 2012. 123(3): p. 409-17.
Mioshi, E., et al., Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival. Neurology, 2014. 82(2): p. 149-55.
Mioshi, E., et al., A novel tool to detect behavioural symptoms in ALS. Amyotroph Lateral Scler Frontotemporal Degener, 2014. 15(3-4): p. 298-304.
Hsieh, S., et al., The Mini-Addenbrooke’s Cognitive Examination: A new assessment tool for dementia. Dementia and Geriatric Cognitive Disorders, 2014. 39(1-2): p. 1-11.
The 2019 Federal Budget has delivered a win for people living with brain disorders in Australia, with a $7million funding boost for research aimed at developing improved models of care. The clinical and research translation program, led by the Mindgardens Neuroscience Network (Mindgardens), will build new models of care to address the staggering burden of brain disorders in Australia. The disease burden associated […]